Skip to main content

NCBiotech News

  • Clinical data company TARGET PharmaSolutions of Chapel Hill will collaborate with Dublin-based Allergan, a global pharmaceutical company, to study a major liver disease and future treatment options for it.
  • A genetic test developed by MultiGEN Diagnostics of Greensboro is 1,000 times more sensitive than current methods in detecting a key mutation in cancer, according to a newly published scientific paper.
  • The North Carolina Biotechnology Center awarded 14 loans and grants totaling $1.6 million to companies, universities and other bioscience entities in the third quarter of its 2016-2017 fiscal year ending March 31.
  • WUNC, the University of North Carolina Public Radio station, devoted a 12-minute segment of the weekday show “The State of Things” to the state’s life science sector today.
  • Clinical Sensors Inc., a small diagnostic device company in Research Triangle Park, has won two grants totaling more than $1.5 million from the National Institutes of Health (NIH) to support the development of its point-of-care device that measures a patient's blood nitric oxide level within a few seconds.
  • By Barry Teater, NCBiotech Writer NeuroTronik Inc. of Durham has closed on $23.1 million in Series B preferred stock financing to advance its therapy for treating acute heart failure in hospitals.
  • Craft Technologies, a small contract laboratory in Wilson, has received federal certification in the measurement of estradiol, a metabolite of the sex hormone estrogen that is useful in assessing many diseases and disorders.
  • RTP's AgTech Accelerator has made a $5 million investment to establish a new animal health company, Skyline Vet Pharma, to in-license and develop drug delivery technologies aimed at improving veterinary treatment of companion animals – primarily dogs and cats.
  • Three young North Carolina life science companies are competing in this year’s Buzz of BIO competition.
  • Middle and high school teachers have an opportunity to expand their knowledge of agricultural biotechnology in a pair of Industry in the Classroom workshops beginning in July, organized by the North Carolina Biotechnology Center.
  • Triangle attorney and business leader Ravila Gupta will become president and CEO of the Council for Entrepreneurial Development (CED), effective April 17.
  • The Wake Forest Institute for Regenerative Medicine (WFIRM) is leading a $20 million effort to apply advanced manufacturing techniques that can speed the regenerative medicine process for creating replacement tissues and organs.
  • Shengmin Sang, Ph.D., associate professor and lead scientist in the Center for Excellence in Post-Harvest Technologies ​at NCA&T labs at the NCRC in Kannapolis, has parlayed early grant support from NCBiotech into growing scientific and commercial recognition.
  • Five of the Piedmont Triad region’s most successful individuals and organizations working in the biosciences have been honored with 2017 Excellence Awards at Triad BioNight, a biennial celebration of the region’s life science sector organized by the Piedmont Triad Office of the North Carolina Biotechnology Center.
  • The newly published 2016 Evidence and Opportunity: Impact of Life Sciences in North Carolina says the state now has over 650 life science companies that directly employ 63,000 people and account for 260,000 jobs overall, providing $2.2 billion in state and local tax revenues and $86 billion in total economic impact.
  • Last week we announced that RTP’s own UVision360 Hysteroscopy Systems was competing in the MD+DI annual Medtech Startup Showdown. With the support of our scientific community, UVision has made it to Round 2.
  • Shengmin Sang, Ph.D., associate professor and lead scientist in the Center for Excellence in Post-Harvest Technologies at North Carolina Agricultural and Technical State University, was awarded the inaugural Innovation for Impact $11,000 Grand Prize Thursday night, March 30, for his research to prevent colon cancer by pairing the classic wonder drug aspirin with an active ingredient in ginger.
  • Wilmington-based contract research organization Pharmaceutical Product Development (PPD) has launched a clinical research associates apprenticeship program targeted at military veterans with medical backgrounds.
  • RTP's UVision 360 has been chosen by Medical Device and Diagnostic Industry (MD+DI), a print and online magazine, to participate in its annual Medtech Startup Showdown. North Carolina's life science and technology community can ensure one of our own makes it to Round 2 by voting now.
  • Humacyte, a Research Triangle Park-based biotechnology company focused on regenerative medicine, has won one of the first Regenerative Medicine Advanced Therapy (RMAT) designations from the U.S. Food and Drug Administration

Pages

Subscribe to News & Events